Molecular Discovery and Development of Biologically Active CompoundsMolecular Discovery and Development of Biologically Active CompoundsMolecular Discovery and Development of Biologically Active CompoundsMolecular Discovery and Development of Biologically Active Compounds
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy

Molecular Discovery and Development of Biologically Active Compounds

 

  • In our lab we mainly focus on drug discovery and development of various therapeutic targets such as Neurodegenerative Disorders (ALS, Alzheimer’s and Parkinson’s disease etc.), and Inflammatory Disorders (COPD, RA), GPCRs for the treatment of Diabetic Disorders (NIDDM), Cancer, Cardiovascular Disorders, Obesity, and other Metabolic Disorders.

 

  • We are also very interested in research and development with an emphasis in design and synthesis of both symmetric and asymmetric organic drug-like molecules leading to new drug substances and natural products as well as the discovery of drugs to treat unmet medical needs in the world.

 

  • Moreover we are investigating to deeply understand the catalytic asymmetric induction reactions and their mechanisms towards the development of new enantioselective catalysts and their applications in the synthesis of biologically active agents.

 

for details

Research Focus

Team
Dr. Mustafa Güzel

Share

SOCIAL MEDIA

SHORTCUT LINKS

 

  • Contact
  • Corporate Identity
  • Referrence Guide
  • Request Forms
  • Sabita 360°
  • Sabita Society
  • Social

OUR MISSION

Translation of Scientific Findings From Bench to Bedside

  • Read More
  • © 2025 Medipol University | SABITA Research Institute for Health Sciences and Technologies
    [contact-form-7 id="50" title="Contact form 1"]